Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734177 | SCV000862300 | likely benign | not specified | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000891406 | SCV001035222 | likely benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000891406 | SCV001840129 | benign | not provided | 2021-04-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000891406 | SCV004129425 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | KMT2A: BP4 |
Breakthrough Genomics, |
RCV000891406 | SCV005212839 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003965546 | SCV004780629 | benign | KMT2A-related disorder | 2021-11-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |